Industry Symposia

These sessions do not form part of the CME program.

Friday, September 12, 2025

09:30-10:15
Sala San Martin

Mid-morning Industry Symposium
Supported by MSD

Topic: Controversies in neoadjuvant and adjuvant management of triple negative breast cancer
Speaker: Luis Schwarz, Lima, Peru

15:45-16:30
Sala San Martin

Mid-afternoon Industry Symposium
Supported by AstraZeneca

Topic: HER2-low and ultra-low in metastatic breast cancer
Speakers: Silvia Falcón, Lima, Peru and Enrique Alanya, Lima, Peru

Saturday, September 13, 2025

09:30-10:15
Sala San Martin

Mid-morning Industry Symposium
Supported by PreludeDx and Ambios

Topic: Limitations of clinicopathology and why DCISionRT is changing practice in DCIS radiation decisions
Speaker: Bruce Mann, Melbourne, Australia

15:45-16:30
Sala San Martin

Mid-afternoon Industry Symposium
Supported by Novartis

Topic: Optimizing the management of early HR+ breast cancer: Evidence and perspectives
Speaker: Henry Gomez, Lima, Peru